Edition:
United States

Stentys SA (STEN.PA)

STEN.PA on Paris Stock Exchange

2.37EUR
28 Apr 2017
Change (% chg)

€0.01 (+0.42%)
Prev Close
€2.36
Open
€2.40
Day's High
€2.40
Day's Low
€2.37
Volume
17,001
Avg. Vol
42,475
52-wk High
€3.29
52-wk Low
€1.91

STEN.PA

Chart for STEN.PA

About

Stentys SA is a French-based company specialized in the development of a new generation of stents for the treatment of acute myocardial infarction or coronary artery disease. It's main product STENTYS Stent, self-expanding coronary bare-metal stent system, is indicated for the treatment of Acute Coronary Syndrome. The Company's... (more)

Overall

Beta: 0.83
Market Cap(Mil.): €42.18
Shares Outstanding(Mil.): 17.87
Dividend: --
Yield (%): --

Financials

  STEN.PA Industry Sector
P/E (TTM): -- 34.67 30.12
EPS (TTM): -0.50 -- --
ROI: -47.26 12.55 13.28
ROE: -51.50 14.56 14.44

BRIEF-Stentys reports 22 pct increase in Q1 revenues

* Q1 revenue EUR 1.8 million ($1.95 million) versus EUR 1.5 million year ago

Apr 24 2017

BRIEF-Stentys FY operating loss shrinks to 8.3 mln euros

* FY operating loss of is 8.3 million euros versus a loss of 9.5 million euros a year ago

Mar 21 2017

BRIEF-Stentys 2016 annual revenues up 20 pct at 7.3 million euros

* 2016 annual revenues up 20 pct at 7.3 million euros ($7.78 million)

Jan 12 2017

More From Around the Web

Earnings vs. Estimates